This is a dummy test for home page
(Reuters) – Tetraphase Pharmaceuticals Inc said on Tuesday its lead experimental antibiotic to treat serious infections did not meet the main goals in a late-stage study, sending its shares plunging more than 60 percent in after-market trading.
Source: Reuters Medical News
(Reuters Health) – Physicians at some of the nation’s most elite medical schools don’t receive three months of paid parental leave that doctors recommend for the health of mothers and babies, a U.S. study has found.
Source: Reuters Medical News
(Reuters Health) – Women are more likely to develop breast cancer when a mother or sister had this disease, and the risk associated with family history doesn’t appear to diminish with age, a U.S. study suggests.
Source: Reuters Medical News
(Reuters) – A federal judge has ruled the U.S. Justice Department can move forward with a lawsuit claiming UnitedHealth Group Inc wrongly retained more than $1 billion from the government healthcare program Medicare.
Source: Reuters Medical News
(Reuters) – Walgreens’ potential move to buy a drug distributor in which it already has a 26 percent stake has some analysts questioning the logic and wondering if it would be enough to compete in an evolving U.S. healthcare sector.
Source: Reuters Medical News
Reuters Health – Cancer survivors who face a higher financial burden with their treatment and recovery tend to report lower quality of life and higher distress, a new study shows.
Source: Reuters Medical News
(Reuters) – German biotech firm CureVac has secured more financial backing for vaccine development projects from its investor the Bill & Melinda Gates Foundation, working on jabs to prevent malaria and influenza.
Source: Reuters Medical News
LONDON (Reuters) – European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.
Source: Reuters Medical News
ZURICH (Reuters) – Novartis’s Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market.
Source: Reuters Medical News
BURIRAM, Thailand (Reuters) – Loud cheers erupt as two boys trade punches at a boxing ring in Thailand’s northeastern province of Buriram.
Source: Reuters Medical News